title: The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
abstract: Roly Gosling and Lorenz von Seidlein consider a potential future development plan for the RTS,S/AS01 malaria vaccine.
authors.affiliation: Global Health Group, University of California, San Francisco, San Francisco, California, United States of America.
authors.forename: Roly
authors.initials: R
authors.lastname: Gosling
authors.affiliation: Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand.
authors.forename: Lorenz
authors.initials: L
authors.lastname: von Seidlein
mesh_terms: D003362:Cost-Benefit Analysis; D017277:Drug Approval; D016527:Drug Costs; D005544:Forecasting; D005102:Health Expenditures / Q000639:trends; D006801:Humans; D017589:Immunization Programs / Q000191:economics / Q000639:trends*; D007115:Immunization Schedule; D007223:Infant; D017780:Malaria Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D016778:Malaria, Falciparum / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control* / Q000635:transmission; D018579:Patient Selection; D010963:Plasmodium falciparum / Q000276:immunology*; D012922:Social Change; D013997:Time Factors; D016896:Treatment Outcome; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics
chemical_list: D017780:Malaria Vaccines; C577001:RTS,S-AS01 vaccine; D014614:Vaccines, Synthetic